Precigen, Inc. (PGEN)
6.19
-0.20
(-3.13%)
USD |
NASDAQ |
Oct 23, 16:00
6.185
0.00 (0.00%)
After-Hours: 20:00
Precigen Price : 6.19 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 6.35 | 6.38 | 6.15 | 6.19 | 4.347M |
| Oct 22, 2026 | 6.50 | 6.63 | 6.280 | 6.39 | 6.254M |
| Oct 21, 2026 | 6.79 | 6.92 | 6.57 | 6.60 | 5.970M |
| Oct 20, 2026 | 6.62 | 6.945 | 6.51 | 6.83 | 6.174M |
| Oct 19, 2026 | 6.45 | 6.68 | 6.305 | 6.66 | 4.141M |
| Oct 16, 2026 | 7.19 | 7.22 | 6.305 | 6.385 | 5.488M |
| Oct 15, 2026 | 7.31 | 7.55 | 7.17 | 7.195 | 3.953M |
| Oct 14, 2026 | 7.48 | 7.70 | 7.33 | 7.355 | 4.197M |
| Oct 13, 2026 | 7.60 | 7.71 | 7.48 | 7.48 | 2.404M |
| Oct 12, 2026 | 7.77 | 7.87 | 7.63 | 7.66 | 2.163M |
| Oct 09, 2026 | 7.595 | 7.840 | 7.475 | 7.81 | 3.384M |
| Oct 08, 2026 | 7.49 | 7.64 | 7.40 | 7.60 | 3.830M |
| Oct 07, 2026 | 7.38 | 7.75 | 7.35 | 7.54 | 4.153M |
| Oct 06, 2026 | 7.79 | 7.90 | 7.490 | 7.55 | 5.140M |
| Oct 05, 2026 | 8.51 | 8.60 | 7.55 | 7.74 | 10.25M |
| Oct 02, 2026 | 8.30 | 8.55 | 8.18 | 8.54 | 6.363M |
| Oct 01, 2026 | 8.50 | 8.64 | 8.19 | 8.21 | 4.614M |
| Sep 30, 2026 | 8.13 | 8.98 | 8.09 | 8.56 | 11.69M |
| Sep 29, 2026 | 7.80 | 8.10 | 7.80 | 8.05 | 4.138M |
| Sep 28, 2026 | 7.61 | 7.86 | 7.50 | 7.81 | 3.491M |
| Sep 25, 2026 | 8.08 | 8.27 | 7.63 | 7.75 | 6.564M |
| Sep 24, 2026 | 7.37 | 7.755 | 7.325 | 7.70 | 4.618M |
| Sep 23, 2026 | 7.95 | 8.01 | 7.19 | 7.44 | 5.564M |
| Sep 22, 2026 | 7.64 | 8.04 | 7.52 | 7.89 | 5.329M |
| Sep 21, 2026 | 7.84 | 7.91 | 7.63 | 7.70 | 3.240M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 21.42 |
| Aldeyra Therapeutics, Inc. | 0.6497 |
| Repligen Corp. | 176.93 |
| AC Immune SA | 2.42 |
| Amgen, Inc. | 439.26 |
Price Related Metrics
| PS Ratio | 25.80 |
| PEG Ratio | -0.036 |
| Price to Book Value | 50.85 |
| Earnings Yield | -17.76% |
| Market Cap | 2.216B |
| PEGY Ratio | -0.036 |